Valuation — not yet established
No valuation for Carmot Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($310.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Carmot Therapeutics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2023 | Later Stage VC (Series E) | $150.0M | ▮ | ▮ |
| Jul 2022 | Later Stage VC (Series D) | $160.0M | ▮ | ▮ |
| Sep 2020 | Early Stage VC | $26.3M | ▮ | ▮ |
| Aug 2017 | Early Stage VC | $10.8M | ▮ | ▮ |
| Jun 2012 | Seed Round | $500K | ▮ | ▮ |
How Carmot Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Carmot Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Carmot Therapeutics raised?
- Carmot Therapeutics has raised $310.0M in total funding across 5 recorded rounds.
- When did Carmot Therapeutics last raise?
- Carmot Therapeutics last raised in May 2023 (Later Stage VC (Series E)), raising $150.0M.